Free Trial

Tounjian Advisory Partners LLC Makes New Investment in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Tounjian Advisory Partners LLC acquired a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 3,334 shares of the financial services provider's stock, valued at approximately $268,000.

A number of other hedge funds also recently added to or reduced their stakes in MET. Tallon Kerry Patrick acquired a new stake in MetLife during the 4th quarter worth approximately $260,000. Brighton Jones LLC lifted its position in MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after acquiring an additional 351 shares during the period. Golden State Wealth Management LLC acquired a new stake in MetLife during the 4th quarter worth approximately $44,000. Apollon Wealth Management LLC lifted its position in MetLife by 2.9% during the 4th quarter. Apollon Wealth Management LLC now owns 19,180 shares of the financial services provider's stock worth $1,570,000 after acquiring an additional 535 shares during the period. Finally, Kingsview Wealth Management LLC lifted its position in MetLife by 48.2% during the 4th quarter. Kingsview Wealth Management LLC now owns 5,779 shares of the financial services provider's stock worth $473,000 after acquiring an additional 1,880 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Price Performance

MET stock traded down $1.77 during midday trading on Friday, hitting $77.22. 3,450,695 shares of the stock were exchanged, compared to its average volume of 3,386,122. The stock's 50-day moving average price is $76.56 and its 200-day moving average price is $80.70. The stock has a market cap of $51.84 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 0.65 and a beta of 0.86. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). The firm had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. MetLife had a return on equity of 20.42% and a net margin of 6.19%. The business's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.83 earnings per share. Research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 6th were given a dividend of $0.5675 per share. This is an increase from MetLife's previous quarterly dividend of $0.55. The ex-dividend date of this dividend was Tuesday, May 6th. This represents a $2.27 annualized dividend and a yield of 2.94%. MetLife's dividend payout ratio (DPR) is presently 36.91%.

MetLife declared that its board has authorized a stock repurchase program on Wednesday, April 30th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on MET. Keefe, Bruyette & Woods reduced their price target on MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Morgan Stanley raised their price target on MetLife from $94.00 to $99.00 and gave the company an "overweight" rating in a report on Monday, May 19th. Cowen reissued a "buy" rating on shares of MetLife in a report on Friday, March 7th. Wells Fargo & Company raised their price target on MetLife from $91.00 to $94.00 and gave the company an "overweight" rating in a report on Tuesday, May 6th. Finally, Piper Sandler raised their price target on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, MetLife presently has a consensus rating of "Moderate Buy" and an average target price of $94.17.

Check Out Our Latest Research Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines